B
Benitec Biopharma Inc. (BNTC)
NCM – Real vaqt narxi. Valyuta: USD
11.84
-0.24 (-1.99%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
11.84
-0.24 (-1.99%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Benitec Biopharma Inc., klinik bosqichdagi biotexnologiya kompaniyasi, yangi genetik dorilarni ishlab chiqishga qaratilgan. Uning Silence and Replace, DKK-yo'naltirilgan RNK shovqin platformasi RNK shovqinini gen terapiyasi bilan birlashtirib, kasallikka sabab bo'lgan genlarni barqaror jim qilish va bir martalik terapevtik konstruktni yuborishdan so'ng normal almashtirish genlarini bir vaqtda etkazib berishni ta'minlaydigan dorilarni yaratadi. Kompaniya ko'z-farengeal mushak distrofiyasiga bog'liq disfagiyani davolash uchun kasallikka sabab bo'lgan genning ekspressiyasini jim qilish uchun mo'ljallangan AAV asosidagi gen terapiyasi BB-301ni ishlab chiqmoqda. Benitec Biopharma Inc. Hayward, Kaliforniyada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Claudia Kloth Ph.D. | Senior Vice President of Manufacturing |
| Dr. Jerel A. Banks M.D., Ph.D. | Executive Chairman & CEO |
| Dr. Michael Graham | Head of Discovery & Founding Scientist |
| Ms. Megan Joan Boston B.Com., C.A. | CFO, Secretary & Director |
| Ms. Sophie Mukadam | Chief Operating Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-20 | 10-K/A | d226768d10ka.htm |
| 2026-02-12 | 8-K | bntc-20260212.htm |
| 2026-02-12 | 10-Q | bntc-20251231.htm |
| 2026-01-30 | S-3 | d10746ds3.htm |
| 2025-12-02 | 8-K | bntc-20251201.htm |
| 2025-11-14 | 8-K | d811784d8k.htm |
| 2025-11-12 | DEFA14A | d75431ddefa14a.htm |
| 2025-11-07 | 8-K | d53447d8k.htm |
| 2025-11-03 | 8-K | bntc-20251102.htm |
| 2025-10-14 | DEF 14A | d32674ddef14a.htm |